中国新生儿筛查项目的最新质量调查与评估。
Up-to-date quality survey and evaluation of neonatal screening programs in China.
机构信息
National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China.
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
出版信息
BMC Pediatr. 2024 Jan 20;24(1):65. doi: 10.1186/s12887-024-04528-1.
AIMS
To thoroughly evaluate the quality of the entire process of neonatal screening (NBS) in China.
METHODS
We collected survey questionnaires from 54.4% (135/248) of NBS institutions in China and conducted on-site visits to 20 of these facilities to validate the data. The quality performance of the institutions was evaluated, and differences across various factors were analysed.
RESULTS
Merely 62.5% of the provinces had acceptable performance in neonatal screening. Institutions with limited staff were more prone to organizational management shortcomings. Institutions in provinces with a per capita GDP below 10,000 USD exhibited lower quality control levels than those with a per capita GDP between 10,000 and 15,000 USD. Obstetrics departments have a lower awareness of quality control compared to other blood collection facilities.
CONCLUSIONS
A nationwide, comprehensive quality control system for continuous enhancements in quality management, screening, diagnosis, and treatment is imperative to ensure prompt diagnosis and intervention.
目的
全面评估中国新生儿筛查（NBS）全过程的质量。
方法
我们收集了中国 54.4%（135/248）的 NBS 机构的调查问卷，并对其中 20 家机构进行了现场访问以验证数据。评估了机构的质量表现，并分析了不同因素之间的差异。
结果
仅有 62.5%的省份在新生儿筛查方面表现出可接受的性能。人员有限的机构更容易出现组织管理方面的缺陷。人均 GDP 低于 10000 美元的省份的机构比人均 GDP 在 10000 至 15000 美元之间的机构的质量控制水平更低。与其他采血机构相比，妇产科部门对质量控制的认识较低。
结论
需要建立一个全国性的、全面的质量控制系统，以不断加强质量管理、筛查、诊断和治疗，以确保及时诊断和干预。
Zotero 插件